View in EDS

A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer.

Saved in:
Bibliographic Details
Title: A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer.
Authors: Knox, Jennifer J.1 (AUTHOR) Jennifer.knox@uhn.ca, McNamara, Mairéad G.2 (AUTHOR), Bazin, Igor S.3 (AUTHOR), Oh, Do-Youn4 (AUTHOR), Zubkov, Oleksii.5 (AUTHOR), Breder, Valeriy3 (AUTHOR), Bai, Li-Yuan6 (AUTHOR), Christie, Alan7 (AUTHOR), Goyal, Lipika8,9 (AUTHOR), Cosgrove, David P.10 (AUTHOR), Springfeld, Christoph11 (AUTHOR), Sjoquist, Katrin M.12 (AUTHOR), Park, Joon Oh13 (AUTHOR), Verdaguer, Helena1,14 (AUTHOR), Braconi, Chiara15 (AUTHOR), Ross, Paul J.16 (AUTHOR), De Gramont, Aimery17 (AUTHOR), Shroff, Rachna T.18 (AUTHOR), Zalcberg, John R.19 (AUTHOR), Palmer, Daniel H.20 (AUTHOR)
Source: Journal of Hepatology. Aug2025, Vol. 83 Issue 2, p358-366. 9p.
Database: Academic Search Ultimate
Description
ISSN:01688278
DOI:10.1016/j.jhep.2025.01.040